KUSURI NO AOKI HOLDINGS CO.,LTD. (JP:3549)
:3549
Want to see JP:3549 full AI Analyst Report?
Top Page
KUSURI NO AOKI HOLDINGS CO.,LTD.
(3549)
Select Model
Select Model
Rating:67Neutral
Price Target:
¥3,749.00
▼(-0.82% Downside)
Action:Reiterated
Date:11/01/25
KUSURI NO AOKI HOLDINGS CO.,LTD. has strong financial performance with robust revenue growth and profitability, but faces challenges in cash flow management. Technical analysis shows mixed signals, with short-term weakness but long-term strength. The valuation is fair, though the low dividend yield may not appeal to income investors.
Positive Factors
Strong Revenue Growth
Sustained top-line expansion indicates ongoing demand for the company’s retail offering and successful execution at store level. Revenue momentum supports scale benefits, supplier leverage and reinvestment capacity, underpinning durable growth over the next several quarters.
Negative Factors
Severe Free Cash Flow Decline
A collapse in free cash flow constrains the company’s ability to self‑fund expansion, service obligations, and return capital. Persistent FCF weakness increases reliance on external financing and heightens vulnerability to capex cycles or slower sales periods over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
Sustained top-line expansion indicates ongoing demand for the company’s retail offering and successful execution at store level. Revenue momentum supports scale benefits, supplier leverage and reinvestment capacity, underpinning durable growth over the next several quarters.
Read all positive factors
KUSURI NO AOKI HOLDINGS CO.,LTD. (3549) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥348.71B
Dividend Yield0.41%
Average Volume (3M)203.46K
Price to Earnings (P/E)18.0
Beta (1Y)0.56
Revenue Growth14.59%
EPS Growth7.84%
CountryJP
Employees4,735
SectorHealthcare
Sector Strength45
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)226.96
Shares Outstanding95,616,980
10 Day Avg. Volume259,620
30 Day Avg. Volume203,460
Financial Highlights & Ratios
PEG Ratio0.58
Price to Book (P/B)2.46
Price to Sales (P/S)0.71
P/FCF Ratio800.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)210.37
Revenue Forecast (FY)¥639.26B
KUSURI NO AOKI HOLDINGS CO.,LTD. Business Overview & Revenue Model
Company Description
KUSURI NO AOKI HOLDINGS CO.,LTD. (3549) is a prominent Japanese company primarily engaged in the retail of pharmaceuticals, healthcare products, and cosmetics. The company operates a chain of drugstores across Japan, focusing on providing a wide r...
How the Company Makes Money
The company primarily makes money through retail sales at its drugstore locations. Key revenue streams include: (1) sales of prescription pharmaceuticals, where revenue is generated by dispensing prescriptions through in-store pharmacies; (2) sale...
KUSURI NO AOKI HOLDINGS CO.,LTD. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
60
Neutral
| Breakdown | TTM | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 641.21B | 501.47B | 436.88B | 378.87B | 328.33B | 305.88B |
| Gross Profit | 154.08B | 120.47B | 106.29B | 94.64B | 80.98B | 82.82B |
| EBITDA | 50.69B | 39.82B | 30.64B | 27.01B | 23.08B | 24.10B |
| Net Income | 22.82B | 17.79B | 12.31B | 12.33B | 9.84B | 12.06B |
Balance Sheet | ||||||
| Total Assets | 390.46B | 352.46B | 303.45B | 276.33B | 236.08B | 197.40B |
| Cash, Cash Equivalents and Short-Term Investments | 80.63B | 47.73B | 49.13B | 42.87B | 26.35B | 15.73B |
| Total Debt | 140.22B | 99.32B | 98.78B | 89.50B | 78.13B | 54.39B |
| Total Liabilities | 247.86B | 206.70B | 186.03B | 177.78B | 149.14B | 119.72B |
| Stockholders Equity | 142.60B | 145.76B | 117.42B | 98.55B | 86.93B | 77.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 448.00M | 7.20B | 10.84B | -6.26B | -8.19B |
| Operating Cash Flow | 0.00 | 22.17B | 26.86B | 31.25B | 20.29B | 13.85B |
| Investing Cash Flow | 0.00 | -31.08B | -21.10B | -22.26B | -27.77B | -25.53B |
| Financing Cash Flow | 0.00 | 7.67B | 344.00M | 7.53B | 18.10B | 8.10B |
KUSURI NO AOKI HOLDINGS CO.,LTD. Technical Analysis
Neutral
3780.00
Price Trends
3699.74
Negative
3881.86
Negative
3880.59
Negative
Market Momentum
-53.85
Negative
51.26
Neutral
74.35
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3549, the sentiment is Neutral. The current price of 3780 is above the 20-day moving average (MA) of 3642.09, above the 50-day MA of 3699.74, and below the 200-day MA of 3880.59, indicating a neutral trend. The MACD of -53.85 indicates Negative momentum. The RSI at 51.26 is Neutral, neither overbought nor oversold. The STOCH value of 74.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3549.
KUSURI NO AOKI HOLDINGS CO.,LTD. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥204.51B | 12.51 | ― | 2.35% | 7.84% | 17.59% | |
68 Neutral | ¥440.92B | 14.05 | 11.37% | 3.04% | 5.08% | 2.07% | |
67 Neutral | ¥348.71B | 18.01 | ― | 0.41% | 14.59% | 7.84% | |
66 Neutral | ¥537.25B | 11.47 | 15.71% | 0.96% | 15.07% | 72.98% | |
62 Neutral | ¥893.73B | 21.61 | ― | 1.72% | ― | ― | |
60 Neutral | ¥461.84B | 14.65 | ― | 0.93% | 6.74% | 6.60% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
3,647.00
202.59
5.88%
JP:9989
Sundrug Co
3,771.00
-513.29
-11.98%
JP:7649
Sugi Holdings Co
2,850.50
-298.37
-9.48%
JP:3391
TSURUHA Holdings
1,986.50
-238.01
-10.70%
JP:3148
Create SD Holdings Co., Ltd.
3,235.00
151.22
4.90%
JP:3349
COSMOS Pharmaceutical Corporation
5,802.00
-2,889.92
-33.25%
KUSURI NO AOKI HOLDINGS CO.,LTD. Corporate Events
Kusuri No Aoki to Add Long-Term Incentives to Shareholder Benefit Program
May 14, 2026
Kusuri No Aoki Holdings has approved an expansion of its shareholder benefit program by introducing long-term holding incentives tied to its May 20 annual record date, starting with the fiscal year ending in 2027. The initiative aims to enhance th...
Kusuri No Aoki Reports No Share Buybacks Yet Under Authorized Program
May 7, 2026
Kusuri No Aoki Holdings Co., Ltd. reported on the status of its share buyback program authorized under Article 459 of the Companies Act and its Articles of Incorporation, as approved by the board on December 25, 2025. The authorization permits mar...
Kusuri no Aoki Posts April Sales Growth as Store Network Expands
May 7, 2026
Kusuri no Aoki Holdings reported April 2026 all-store sales at 109.5% of the previous year, with existing-store sales edging up 0.2%, as higher average spending per customer offset softer traffic at mature locations. The figures, based on prelimin...
Kusuri No Aoki Reports No Progress on Authorized Share Buyback
Apr 2, 2026
Kusuri No Aoki Holdings has reported on the progress of its board-approved share buyback program authorized in December 2025, which allows purchases of up to 6 million shares, or 6.32% of outstanding stock, for a total cost of up to 24 billion yen...
Kusuri no Aoki Boosts March Sales as Regional Store Expansion Accelerates
Apr 2, 2026
Kusuri no Aoki Holdings reported that in March 2026, all-store sales rose 11.8% year on year, supported by a 9.1% increase in customer traffic and higher average spending per customer, while existing-store sales edged up 1.5%. This indicates that ...
Kusuri No Aoki Posts Higher Nine-Month Earnings, Plans 40th Anniversary Dividend Boost
Apr 2, 2026
Kusuri No Aoki Holdings reported consolidated net sales of ¥422.8 billion for the nine months ended February 20, 2026, up 13.7% year on year, with operating profit rising 7.4% and profit attributable to owners of parent climbing 10.3%. Earnin...
Kusuri No Aoki Leaves Share Buyback Authorization Untapped in February
Mar 6, 2026
Kusuri No Aoki Holdings Co., Ltd. reported that, despite having board authorization for a significant share buyback program, it did not purchase any of its own shares between February 1 and February 28, 2026. The company still retains approval to ...
Kusuri No Aoki Posts Solid February Sales and Expands Store Network Across Japan
Mar 5, 2026
Kusuri No Aoki Holdings reported February 2026 all-store sales at 109.8% of the prior-year level, with existing-store sales at 99.8%, reflecting steady overall growth but slightly softer performance at mature locations. Customer traffic at existin...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.